Inhibition	O
of	O
Inflammatory	O
Gene	O
Transcription	O
by	O
IL	O
-	O
10	O
Is	O
Associated	O
with	O
Rapid	O
Suppression	O
of	O
Lipopolysaccharide	O
-	O
Induced	O
Enhancer	O
Activation	O
.	O


IL	O
-	O
10	O
limits	O
the	O
magnitude	O
of	O
inflammatory	O
gene	O
expression	O
following	O
microbial	O
stimuli	O
and	O
is	O
essential	O
to	O
prevent	O
inflammatory	O
disease	O
;	O
however	O
,	O
the	O
molecular	O
basis	O
for	O
IL	O
-	O
10	O
-	O
mediated	O
inhibition	O
remains	O
elusive	O
.	O


Using	O
a	O
genome	O
-	O
wide	O
approach	O
,	O
we	O
demonstrate	O
that	O
inhibition	O
of	O
transcription	O
is	O
the	O
primary	O
mechanism	O
for	O
IL	O
-	O
10	O
-	O
mediated	O
suppression	O
in	O
LPS	B-TISSUE
-	I-TISSUE
stimulated	I-TISSUE
macrophages	E-TISSUE
and	O
that	O
inhibited	O
genes	O
can	O
be	O
divided	O
into	O
two	O
clusters	O
.	O


Genes	O
in	O
the	O
first	O
cluster	O
are	O
inhibited	O
only	O
if	O
IL	O
-	O
10	O
is	O
included	O
early	O
in	O
the	O
course	O
of	O
LPS	O
stimulation	O
and	O
is	O
strongly	O
enriched	O
for	O
IFN	O
-	O
inducible	O
genes	O
.	O


Genes	O
in	O
the	O
second	O
cluster	O
can	O
be	O
rapidly	O
suppressed	O
by	O
IL	O
-	O
10	O
even	O
after	O
transcription	O
is	O
initiated	O
,	O
and	O
this	O
is	O
associated	O
with	O
suppression	O
of	O
LPS	O
-	O
induced	O
enhancer	O
activation	O
.	O


Interestingly	O
,	O
the	O
ability	O
of	O
IL	O
-	O
10	O
to	O
rapidly	O
suppress	O
active	O
transcription	O
exhibits	O
a	O
delay	O
following	O
LPS	O
stimulation	O
.	O


Thus	O
,	O
a	O
key	O
pathway	O
for	O
IL	O
-	O
10	O
-	O
mediated	O
suppression	O
involves	O
rapid	O
inhibition	O
of	O
enhancer	O
function	O
during	O
the	O
secondary	O
phase	O
of	O
the	O
response	O
to	O
LPS	O
.	O
